Table 1.

Baseline Characteristics of All Treated Patients

Characteristic	DL1	DL2	DL3	DL4	DL5	DL6	All Dose Levels
	N = 3	N = 6	N = 6	N = 7	N = 6	N = 4	N = 32
Age – yr
Median	65	57	59	56	57	58	58
Range	62–86	50–75	40–78	42–74	47–78	56–65	40–86
Sex – no (%)
Male	2 (66)	0	3 (50)	3 (43)	0	0	8(25)
Female	1 (33)	6 (100)	3 (50)	4 (57)	6(100)	4(100)	24(75)
ECOG – no (%)
0	0	0	3 (50)	2 (29)	4(66)	2(50)	11(34)
1	3 (100)	6 (100)	3 (50)	5 (71)	2(33)	2(50)	21(66)
Primary Site of Disease –no (%)
Non-Gyn	3(100)	2(33)	3(50)	6(86)	0	0	14(44)
Ovary or Fallopian	0	4 (66)	3(50)	1 (14)	6(100)	4(100)	18(56)
Stage of Disease
II	0	0	1(17)	0	1(17)	0	2(6)
III	0	0	0	1(14)	2(33)	3(75)	6(19)
IV	3(100)	6(100)	5(83)	4(57)	2(33)	1(25)	21(66)
Unknown				2(28)	1(17)	0	3(9)
# Prior Tx
1	2(66)	3(50)	1(17)	2 (29)	1(17)	0	9(28)
2-3	0	0	3(50))	5 (71)	1(17)	0	9(28)
4+	1(33)	3(50)	2(33)	0	4(66)	4(100)	14(44)